Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients (NCT05722977) | Peking Union Medical College Hospital | 2023-02-02 |
Track Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients automatically
Every clearance here is in the API, with alerts when new ones post.